CDSCO 2026 dental drug approval list adds multiple new agents

The Central Drugs Standard Control Organisation published its 2026 approvals list, introducing a set of new antibiotics, local anesthetics and antivirals that are cleared for dental indications in India. These agents are now legally marketable, expanding clinicians’ options for managing oral infections, procedural pain and viral lesions. Availability is nationwide through licensed pharmaceutical distributors, and the approvals align with current dental pharmacotherapy guidelines.